Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation

Published:2023-06 Issue:6 Volume:176 Page:769-778
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Ray Wayne A.¹^ORCID,Chung Cecilia P.²,Stein C. Michael³,Smalley Walter⁴^ORCID,Zimmerman Eli⁵,Dupont William D.⁶^ORCID,Hung Adriana M.²^ORCID,Daugherty James R.¹,Dickson Alyson L.²,Murray Katherine T.³

Affiliation:

1. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee (W.A.R., J.R.D.)

2. Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (C.P.C., A.M.H., A.L.D.)

3. Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee (C.M.S., K.T.M.)

4. Departments of Health Policy and Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (W.S.)

5. Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee (E.Z.)

6. Departments of Health Policy and Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee (W.D.D.)

Funder

National Heart, Lung, and Blood Institute

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference56 articles.

1. Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017

2. Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation

3. Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

4. Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban

5. Antiarrhythmic Drug Therapy for Atrial Fibrillation

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential interactions between medications for rate control and direct oral anticoagulants: Population-based cohort and case-crossover study;Heart Rhythm;2024-06

2. Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban;JAMA;2024-05-14

3. 2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary;Thrombosis and Haemostasis;2024-05-14

4. Racial and Ethnic Disparities in Initiation of Direct Oral Anticoagulants Among Medicare Beneficiaries;JAMA Network Open;2024-05-06

5. Traduction et republication de : « Traitement anticoagulant de la maladie veineuse thromboembolique associée au cancer »;La Revue de Médecine Interne;2024-04